SC Seeks Wider Drug Price Regulation, Questions High Markups on Medicines, Medical Devices

SC seeks wider drug price regulation, questions high markups on medicines, medical devices

A bench of Justices Vikram Nath and Sandeep Mehta took note of the Centre's decision to impose a 30 per cent cap on trade margins for specified cancer drugs but sought to know why similar scrutiny could not extend to other medicines.

Drug price control: Supreme Court questions Centre over steep hospital markups

The Supreme Court questions why drug margin caps cannot cover all medicines and gives the Centre until October 27 to propose price control measures.

'Why only cancer drugs?': SC questions Centre on trade margin cap, seeks wider price regulation

A bench of Justices Vikram Nath and Sandeep Mehta took note of the Centre's decision to impose a 30 per cent cap on trade margins for specified cancer drugs but sought to know why similar scrutiny could not extend to other medicines.

Centre to cap trade margins on cancer drugs, SC calls for broader price review

Centre to cap trade margins on cancer drugs, SC calls for broader price review New Delhi: The Centre on Monday informed the Supreme Court that it has decided to regulate trade margins on anti-cancer medicines by capping them at 30 per cent of the maximum retail price (MRP), while the apex court called for a […]

Centre caps trade margin of anti-cancer drugs at 30%, SC asks why not other medicines - OrissaPOST

New Delhi: Supreme Court Monday said the Centre’s response on capping the trade margin of anti-cancer drugs at 30 per cent of the maximum retail price (MRP) is “hardly anything to be happy about” and questioned why the government cannot cap trade margins of other medicines. The Centre, which has earlier come under severe criticism […]